28 June 2026: Clinical Research
Migraine in the Corporate Sector: Prevalence, Risk Factors, Job Efficiency Impact, and Management Strategies
Azra Batool ABCDE 1, Adeel Aslam DOI: 10.12659/MSM.951082
Med Sci Monit 2026; 32:e951082
Abstract
BACKGROUND: Migraine, a prevalent neurological disorder characterized by recurrent episodes of severe headache, significantly impacts individuals worldwide. This study aimed to evaluate migraine prevalence, identify key risk factors, assess the impact on job performance, and explore commonly used management strategies.
MATERIAL AND METHODS: This cross-sectional study involved corporate sector employees visiting outpatient neurology departments in Pakistan. A questionnaire was developed to quantify the overall burden of migraine. Inferential statistics, including the Mann-Whitney U test and Kruskal-Wallis H test, were used to evaluate group differences. An exploratory factor analysis (EFA) was conducted to confirm the questionnaire’s structural validity.
RESULTS: The questionnaire showed strong reliability (Cronbach’s α=0.81) and validity (S-CVI=0.86, KMO=0.82, P<0.001). Migraines significantly impacted job efficiency (p=0.015), with 43.8% experiencing episodes lasting 4 to 8 h. Gender (P=0.012), age (P=0.029), and income (P=0.045) were significantly associated with migraine burden. The most common triggers were stress (27.7%) and sleep deprivation (23.2%), while over-the-counter medication (62.5%) was the most commonly used treatment. Gender (β=0.23, P=0.012), age (β=-0.19, P=0.029), and income (β=-0.17, P=0.045) significantly predicted the migraine burden. A higher migraine burden significantly predicted lower job efficiency (β=-0.31, P=0.015).
CONCLUSIONS: Migraines have a significant impact on job efficiency in the Pakistani corporate sector, necessitating comprehensive management strategies and targeted interventions to mitigate their effects.
Keywords: Anxiety, Health, Income, Migraine Disorders, Sleep
Introduction
Migraine, a common neurological disorder marked by recurrent severe headaches, greatly affects people worldwide [1]. These episodes often come with symptoms like nausea, photophobia, and phonophobia, which add to the disorder’s disabling nature [2]. The World Health Organization (WHO) ranks migraine as the sixth leading cause worldwide of years lost due to disability (YLD), highlighting its importance as a major public health issue [3]. Globally, migraines affect about 15% of the population, particularly adults aged 25 to 55 years, thereby disrupting some of the most economically productive years [4,5]. This is especially significant in low- and middle-income countries (LMICs) like Pakistan, where the economic burden of lost productivity is worsened by underdeveloped healthcare systems and a lack of supportive workplace policies [6,7].
The pathophysiology of migraine involves complex neurological mechanisms, and its risk factors include genetic predispositions, environmental triggers, and lifestyle factors [8]. In the specific context of Pakistan, a recent study showed that migraine remains a major health concern, with common risk factors such as physical stress and hormonal changes [9]. Additionally, cultural and socioeconomic factors like reliance on faith healers and gender-specific barriers to healthcare contribute to significant underreporting and undertreatment of migraine, making it harder to assess the true burden of the disease in the country [10–13]. Limited access to specialized healthcare and low awareness of migraine among healthcare providers worsen the situation. This results in a dependence on over-the-counter medications instead of personalized treatment plans [9,10,14,15]. The economic impact is also substantial, with notable productivity losses due to work absences and decreased job performance caused by migraine [13].
Migraine-related workplace productivity losses are a major yet under-researched concern in Pakistan’s developing economy [6]. Both absenteeism (missed workdays) and presenteeism (reduced work efficiency while at work) contribute to substantial economic losses. Employees suffering from chronic migraines often struggle with concentration, reduced cognitive function, and frequent work interruptions, making it challenging to meet job demands [16]. Research has shown that workers experiencing migraines are more likely to miss deadlines, request sick leave, or even quit employment due to unmanaged symptoms, which collectively burdens both employers and the economy [17–19]. However, the specific impact on Pakistan’s corporate sector remains unquantified. Furthermore, the absence of formal workplace policies addressing chronic pain conditions in the country exacerbates these issues, leaving employees to resort to self-management strategies [20]. Many individuals suffering from migraine in Pakistan turn to a combination of allopathic and traditional remedies in addition to conventional care. These include home remedies such as herbal teas, essential oils, and dietary modifications, as well as religious and spiritual practices, for symptom relief and management. This is evident in urban corporate settings where stress levels are high [12,21–23]. The efficacy, patterns of use, and interplay between these traditional practices and modern self-medication are poorly understood within the Pakistani workforce, creating a critical knowledge gap. Given this context, there is a clear need for local evidence to inform effective public health and corporate wellness strategies that are both medically sound and culturally congruent. Therefore, this study assessed the impact of migraines on job efficiency specifically and explored the management strategies, including conventional remedies, used by corporate employees in Pakistan. By focusing on these aspects, this research will provide a foundation for informed policy-making that addresses the medical, economic, and sociocultural dimensions of migraine management in the Pakistani workforce.
Material and Methods
STUDY OBJECTIVE AND RESEARCH QUESTION:
This study aimed to assess the burden of migraine among corporate employees in Lahore, Pakistan. The primary research question was: “What is the prevalence of migraine, its associated risk factors, its impact on job efficiency, and the management practices employed by corporate employees presenting at a neurology outpatient department?” In this study, the corporate sector was defined as private organizations in finance, manufacturing, and administrative services employing full-time salaried staff.
STUDY DESIGN, SETTING, AND DURATION:
This questionnaire-based, cross-sectional, quantitative study was conducted in Lahore, Pakistan, from May 2024 to October 2024.
INCLUSION AND EXCLUSION CRITERIA:
Inclusion criteria were: (1) adults aged 18 years and older, (2) a confirmed diagnosis of migraine by a neurologist, (3) currently employed full-time in the corporate sector, and (4) provision of written informed consent.
Exclusion criteria were: (1) individuals with other chronic painful conditions that could confound the assessment of headache impact, (2) those who did not give consent, (3) those with severe psychiatric comorbidities, and (4) inability to understand the questionnaire.
SAMPLING METHOD:
A consecutive sampling technique was used. Every eligible individual who visited the outpatient department during the study period and met the inclusion criteria was invited to participate until the required sample size was achieved. This method was chosen for its practicality in a clinical setting and to minimize selection bias by providing an equal opportunity for all eligible patients during the data collection period [24].
DATA COLLECTION METHOD:
Data were collected in person by the principal investigator (A.B.). A standardized script was developed to introduce the study, obtain consent, and provide neutral instructions, thereby ensuring the questionnaire was completed without influencing responses.
EXPOSURE AND OUTCOME VARIABLES:
Exposure variables included sociodemographic characteristics (age, gender, marital status, income), as well as specific migraine risk factors. The primary Outcome Variables were: (1) Migraine severity score, (2) Overall migraine burden score (low, moderate, high), (3) Impact on job efficiency score, and (4) Migraine management effectiveness score.
DATA COLLECTION TOOL:
The data collection tool had several parts. Part A pertained to the patient’s sociodemographic characteristics, including gender, age group, marital status, and monthly income. In Part B (Prevalence of Migraine), classifications range from mild (scores 0–10) for infrequent and mild symptoms to severe (scores 21+) for chronic and intense migraines. Part C (Risk Factors) sorts respondents into low (0–15), moderate (16–30), and high (31+) risk categories based on how often triggers provoke migraines. Part D (Influence on Job Efficiency) evaluates the impact on work and categorizes it as minimal (0–10), moderate (11–20), or severe (21+). Part E (Management of Migraine Attack) assesses the effectiveness of migraine management on a scale from well-managed (0–10) to poorly managed (21+). The types of questions vary from multiple-choice to Likert scale responses, where symptoms and impact on job efficiency are rated on a 1 (“Never”) to 5 (“Always”) scale, and management practices are assessed on effectiveness (1 “Not effective” to 5 “Very effective”) and usage frequency (1 “Never” to 3 “Always”). The total scores from all sections determine the overall migraine burden as low (0–30), moderate (31–60), or high (61+), providing a comprehensive assessment of severity, triggers, job impact, and management. A Migraine Disability Assessment (MIDAS) questionnaire was used to measure the burden of migraines on patients [27].
QUESTIONNAIRE DEVELOPMENT AND PILOT STUDY:
Questionnaire development was informed by a comprehensive review of relevant literature on migraine and work productivity, including frameworks from established tools like the Migraine Disability Assessment (MIDAS) questionnaire [25]. The instrument was reviewed by an expert panel comprising the principal investigator, a supervisor, a neurologist, and a public health expert to ensure content relevance. A pilot study was conducted on a small sample (N=30) to assess the clarity, reliability, and feasibility of the questionnaire. Based on expert feedback, minor modifications were made. A pilot study was conducted on 30 participants to assess feasibility, clarity, and reliability. Findings from the pilot indicated excellent internal consistency, with a Cronbach’s alpha of 0.89 for the entire instrument. The Content Validity Index (CVI) was calculated at 0.92, confirming the relevance of the items. Exploratory factor analysis (EFA) conducted during the pilot phase supported the hypothesized 4-factor structure of the questionnaire, confirming its construct validity. Detailed results are presented in the Results section.
STUDY SIZE:
The sample size was calculated using the formula [26]:
where Z=1.96 (for 95% confidence level),
ETHICAL CONSIDERATIONS:
Ethics approval was obtained from the Institutional Review Board (IRB) of the University of Lahore (IREC-2024-04H; dated February 1, 2024). Written informed consent was obtained from all participants, and data confidentiality was strictly maintained throughout the study. All questionnaires were assigned a unique code, and any documents linking codes to personal identifiers were stored separately on a password-protected computer accessible only to the principal investigator. Data were anonymized before analysis.
STATISTICAL METHODS:
Data were analyzed using descriptive statistics (n, %) to detail the demographic characteristics of the respondents. The instrument was validated by testing for reliability (Cronbach’s alpha) and validity (content and construct validity) in a preliminary study. Furthermore, the adequacy of the sample size and the suitability of the data for factor analysis were assessed using the Kaiser-Meyer-Olkin (KMO) measure and Bartlett’s test of sphericity. Exploratory factor analysis (EFA) was conducted to validate the questionnaire’s structure. The normality of continuous data was assessed using the Shapiro-Wilk test, and all key outcome variables were found to be non-normally distributed. Given the non-normal distribution of the data, non-parametric inferential tests, such as the Mann-Whitney U test and Kruskal-Wallis H test, were used to assess differences in migraine-related variables across demographic groups. To identify predictors of overall migraine burden and job efficiency impact, multiple linear regression models were applied, and binary logistic regression identified factors associated with poor migraine management. Variable selection was guided by the study’s objectives and relevant literature. Model fit was assessed via R2 and Nagelkerke R2, with significance set at
Results
DEMOGRAPHIC CHARACTERISTICS:
A total of 387 corporate employees with migraine were included in this study. The sample consisted predominantly of women (299, 77.3%) and young adults aged 26 to 35 years (159, 41.1%). Most participants were unmarried (166, 42.9%) or married (153, 39.5%), worked in finance/banking (76, 19.6%) or manufacturing (62, 16.0%), held mid-level positions (149, 38.5%), and earned monthly incomes between PKR 18 001 and 36 000 (142, 36.7%) (Table 1).
RELIABILITY OF QUESTIONNAIRE:
Reliability analysis of the migraine impact questionnaire (N=112) demonstrated good internal consistency (α=0.81 overall). Section-specific reliability varied: Part B (Prevalence) showed acceptable consistency (α=0.73; range=0.70–0.72 if item deleted), while Part C (Risk Factors) exhibited stronger reliability (α=0.84; range=0.81–0.83). Part D (Job Efficiency) maintained moderate consistency (α=0.78; range=0.75–0.77), and Part E (Management) showed the lowest but still marginal reliability (α=0.69; range=0.65–0.68). These results support the questionnaire’s reliability in assessing the multidimensional impacts of migraine.
CVI SCORE OF QUESTIONNAIRE:
The questionnaire demonstrated strong content validity, with an overall scale-level CVI (S-CVI) of 0.86, indicating high relevance across all items. Part B (migraine prevalence) showed particularly robust validity, with Item-level CVI (I-CVI) scores ranging from 0.80 to 1.00 and an average S-CVI of 0.92. Part C (risk factors) maintained good validity (I-CVI: 0.78–0.95; S-CVI: 0.87), as did Part D (job efficiency impact; I-CVI: 0.80–0.90; S-CVI: 0.85). Part E (migraine management) showed slightly lower but acceptable validity (I-CVI: 0.75–0.88; S-CVI: 0.80).
EXPLORATORY FACTOR ANALYSES:
Exploratory factor analysis (EFA) of the migraine impact questionnaire demonstrated strong validity, with a Kaiser-Meyer-Olkin (KMO) measure of 0.82 (indicating sample adequacy) and a significant Bartlett’s test of sphericity (χ2=865.23,
MIGRAINE CHARACTERISTICS AND SYMPTOMS:
Most participants reported having moderate (156, 40.2%) or severe (135, 34.8%) migraines. Migraine without aura was most common (149, 38.4%), and the majority experienced attacks lasting 4 to 8 h (169, 43.8%) with throbbing pain (183, 47.3%). Photophobia (217, 56.1%) and phonophobia (208, 53.7%) were the most frequently reported symptoms, followed by nausea (173, 44.7%) and vomiting (173, 44.7%) (Table 2).
MIGRAINE TRIGGERS/RISK FACTORS AND SYMPTOMS:
Stress (27.7%, n=107) and sleep deprivation (23.2%, n=90) emerged as the most prevalent migraine triggers. Hunger or skipped meals affected 26.8% (n=104) of respondents, while environmental factors such as bright lights (33.0%, n=128) and loud noises (31.3%, n=121) were commonly reported. Dietary triggers included chocolate (24.1%, n=93) and caffeine (25.9%, n=100). The mean overall risk factor score was 28.7 (±10.5). Complete results are shown in Table 3. Nausea was the most prevalent symptom, reported by 35.7% (n=138) of respondents sometimes and 27.7% (n=107) often. Vomiting affected 33.0% (n=128) sometimes and 26.8% (n=104) often. Sensory sensitivities were common, with 32.1% (n=124) frequently experiencing light sensitivity and 30.4% (n=118) having sound sensitivity. Neurological symptoms included tingling/numbness in the extremities (25.0%, n=97 reporting frequent occurrence) and speech difficulties/confusion (31.3%, n=121 sometimes; 26.8%, n=104 often) (Table 3).
EFFECT ON JOB EFFICIENCY:
Migraines often affected the ability to work for 104 (26.8%) respondents, and 73 (18.8%) respondents stated that their ability to work was always affected. Productivity was moderately impaired for 121 (31.3%), and 107 (27.7%) experienced significant impairment. Workload reduction or task changes due to migraines were reported often by 104 (26.8%). Important meetings or deadlines were significantly affected for 97 (25.0%), with 76 (19.6%) reporting a severe impact. Entire work absences due to migraines were reported by 114 (29.5%). The mean overall impact score was 18.5 (±7.3).
MANAGEMENT OF MIGRAINE:
The mean management score was 16.3 (±8.5), with 37.5% (n=145) of respondents classified as poorly managed and 35.7% (n=138) as moderately managed. The most frequently used treatments were over-the-counter (62.5%, n=242) and prescription medications (50.9%, n=197). Hot or cold compresses were rated as very effective by 35.9% (n=139), making them the top-performing intervention. Consistent usage was highest for over-the-counter medications (53.6%, n=207) and trigger avoidance (54.5%, n=211). Detailed results are presented in Table 4.
EFFECTIVENESS OF TREATMENTS USED FOR MANAGING MIGRAINES:
Table 5 summarizes migraine treatment effectiveness ratings across 5 categories. Massage therapy, hot/cold compresses, and rest were most frequently rated as very effective (32.8%, 35.9%, and 31.3%, respectively), while relaxation techniques were also highly rated. Medications were widely used and considered effective, whereas herbal remedies, acupuncture, and yoga showed moderate success. Smoking, exercise, and dietary changes were viewed as least effective. Overall, non-drug approaches, such as massage and rest, alongside medications, were perceived as the most beneficial for migraine relief.
FREQUENCY OF USE OF MIGRAINE MANAGEMENT STRATEGIES:
Prescribed and over-the-counter medications were the most consistently used strategies, with over 50.9% of respondents reporting they “always” take them. Avoiding triggers was also common (54.5% always). Relaxation techniques were frequently used (49.1% always), while herbal remedies were used more variably (42.9% always, 37.5% sometimes).
OVERALL BURDEN OF MIGRAINE AMONG RESPONDENTS:
In this study, 53.6% (n=207) of respondents reported a moderate burden, followed by high (24.1%, n=93) and low (22.3%, n=86) burden levels.
COMPARISON OF MEANS BETWEEN DEPENDENT AND INDEPENDENT VARIABLES:
Table 6 shows that males reported lower migraine prevalence, with a mean of 18.2 (SD=5.4, P=0.032), lower impact on job efficiency, with a mean of 16.5 (SD=7.0, p=0.015), and a lower overall burden score of 61.5 (SD=12.4, P=0.012). The youngest age group, 18–25 years, showed a lower prevalence of migraines, with a mean of 17.8 (SD=5.2, P=0.035) and lower job efficiency impact of 15.9 (SD=6.5, P=0.023), with their overall burden also lower, at 60.1 (SD=12.8, P=0.029). Respondents earning below 18 000 PKR had significantly lower prevalence (17.9; SD=5.5, P=0.045), job efficiency impact (16.4; SD=6.8, P=0.038), and overall burden (61.2; SD=12.9, P=0.031).
CROSS-TABULATION OF DEMOGRAPHICS AND BURDEN OF MIGRAINE AMONG RESPONDENTS:
A significant association was found between gender and burden (P=0.012), with a higher proportion of females (35.7%, n=138) reporting high burden compared to males (21.4%, n=83). Age was also significantly associated with burden (P=0.029), particularly among respondents aged 36 to 45 years, who had the highest proportion of high burden (12.5%, n=48). Marital status showed no significant association with burden (P=0.052), although unmarried respondents (18.8%) reported a moderate burden. Income level was significantly associated with burden (P=0.045), with the highest proportion of high burden observed among those earning above PKR 50 000 (13.4%). Detailed findings are presented in Table 7.
PREDICTORS OF OVERALL MIGRAINE BURDEN AMONG RESPONDENTS:
Multiple linear regression identified age (β=0.74, P=0.002), female gender (β=2.25, P=0.018), stress score (β=0.51, P<0.001), and sleep deprivation (β=0.38, P=0.007) as significant predictors of higher migraine burden, while higher income (β=−0.39, P=0.041) and better management (β=−0.56, P<0.001) were associated with a reduced burden. Multicollinearity was assessed, with all VIF values below 3.75, confirming acceptable collinearity. This model explained 57% of the variance. Results are described in Table 8.
PREDICTORS OF JOB EFFICIENCY IMPACT DUE TO MIGRAINE AMONG RESPONDENTS:
As described in Table 9, for job efficiency impact, significant predictors included migraine frequency (β=0.56, P<0.001), pain severity (β=0.68, P<0.001), stress score (β=0.39, P<0.001), and sleep deprivation (β=0.35, P=0.008). Females reported significantly higher impact (β=1.97, P=0.025), while better management (β=−0.47, P=0.001) improved job efficiency. VIF values remained below 4.21 for all predictors, supporting model stability, with the model explaining 60% of the variance.
PREDICTORS OF POOR MIGRAINE MANAGEMENT AMONG RESPONDENTS:
Logistic regression predicting poor migraine management identified severe migraines (AOR=2.47, P<0.001), frequent attacks (AOR=2.12, P=0.004), and high stress (AOR=1.79, P=0.015) as the strongest predictors. Female gender (AOR=1.58, P=0.084) and age (AOR=1.02, P=0.312) were not significant after adjustment, while income (AOR=0.89, P=0.241) also lost significance. The model demonstrated acceptable fit (Nagelkerke R2=0.41), as shown in Table 10 and Figure 1.
Discussion
The current study assessed the prevalence of migraine, risk factors, occupational impact, and management approaches in Pakistan. Overall, the results reveal a substantial migraine burden that mirrors global patterns yet is distinctly shaped by local sociodemographic realities.
First, the demographic distribution reveals a critical concentration among economically active young adults aged 26 to 35 years (41.1%), consistent with international studies that identify this life stage as a period of peak vulnerability, likely due to career pressures and the development of lifestyle patterns [4,9,27,28]. This vulnerability is further amplified by striking gender disparities, with females comprising 77.3% of cases, a pattern underscoring hormonal fluctuations as a key pathophysiological mechanism that necessitates gender-specific treatment protocols and dedicated research into hormonal therapies [29].
Second, occupational influences emerged as pivotal risk determinants, with significant representation in high-stress sectors, such as finance (19.6%) and manufacturing (16.0%). Our results specifically identified occupational stress (49.1%) and prolonged screen time (47.3%) as the most significant work-related triggers. Consequently, workplace interventions should prioritise stress-reduction strategies and ergonomic adjustments. The preponderance of unmarried respondents (42.9%) further suggests that irregular routines and limited social support can compound occupational stress, creating a feedback loop that exacerbates migraine frequency and severity [30].
Third, these interconnected demographic and occupational insights directly inform the patterns of migraine severity observed. Forty percent experienced moderate and 34.8% severe attacks, rates that parallel global severity trends, such as Viana et al’s (2018) report of 51% chronic migraine in Italy [7]. Moreover, the predominance of migraine without aura (38.4%) aligns with global epidemiological trends [28]. The frequent duration of migraine episodes reported as 4 to 8 h aligns with durations reported in the broader literature, such as a 2014 study by Chang et al [21]. The frequent experience of migraine episodes 1 to 3 times per month in our cohort is indicative of a significant recurrent impact, highlighting the chronic nature of the condition and aligning with other studies [31,32]. Crucially, our data confirm modifiable lifestyle triggers as central drivers: stress, sleep deprivation, and irregular dietary habits were the most frequently reported triggers. This aligns with Johnson et al (2022), who emphasized that effective management must integrate behavioral interventions alongside pharmacotherapy [12]. In Pakistan, where high occupational stress, irregular meals due to demanding schedules, and disrupted sleep are prevalent in the young workforce, these findings necessitate culturally adapted lifestyle protocols as a first-line strategy, complemented by increased accessibility to both acute and preventive medications. Notably, the high incidence of these modifiable triggers strongly suggests that targeted educational programs on lifestyle management could significantly reduce migraine frequency and severity.
Fourth, the significant association of environmental triggers such as loud noises (31.3%) and strong smells (42%) indicates that workplace and public space modifications could benefit sensory-sensitive individuals, as advocated by Holden (2022) [23]. These findings collectively underscore the need for multidimensional intervention strategies.
Fifth, the occupational impact is particularly severe, with 33.0% of respondents experiencing moderate work impairment and 26.8% facing significant disruptions. These findings closely align with Minen et al’s (2022) report of decreased productivity and increased absenteeism among migraine sufferers [33]. This highlights the substantial socioeconomic burden of the condition, particularly in Pakistan, where social safety nets for individuals with health-related work limitations are limited. Our data suggest that workplace adaptations can reduce the impact of migraine. Key modifications include flexible work arrangements during episodes, creating sensory-controlled spaces with reduced lighting and noise, and providing migraine-awareness training for effective management interventions [34–36]. Such measures would be particularly impactful in high-risk sectors, such as finance and manufacturing, identified in our study.
Sixth, management patterns reveal a dual approach: 62.5% frequently use over-the-counter (OTC) medications, while 26.8% use non-pharmacological strategies, such as yoga and meditation. This integrative trend is encouraging, as prior studies validate the efficacy of mindfulness-based practices in chronic migraine [37,38].
Lastly, regression analyses clarify the factors that drive migraine burden. After adjustment for covariates, female gender, younger age (26–35 years, β=−0.19,
Conclusions
LIMITATIONS AND FUTURE IMPLICATIONS:
While this study provides valuable insights into the migraine burden among corporate employees in Pakistan, several limitations must be acknowledged. Purposive sampling from neurology outpatient departments may overrepresent severe cases, limiting generalizability. Excluding rural employees and non-healthcare-seeking individuals creates geographic and socioeconomic gaps. Self-reported data are vulnerable to recall bias, and subjective ratings of severity and job impact lack objective validation. The cross-sectional design precludes causal inferences, and the absence of longitudinal data hinders understanding of migraine progression and treatment outcomes. The cultural context was insufficiently explored, despite mention of traditional remedies; no qualitative data were collected to examine self-medication practices or workplace stigma. Future research should include longitudinal studies to assess treatment adherence and economic impact, as well as mixed-methods designs to explore cultural practices, stigma, and gender-specific barriers. Clinical validation of self-reported data and targeted interventions for high-risk industries is also needed. Clinically, gender-specific protocols, improved access to preventive medications, and integrative care models that combine pharmacotherapy with culturally accepted strategies (eg, yoga, dietary changes) are needed.
Data Availability
The data underlying this article can be obtained from the corresponding author upon reasonable request.
Tables
Table 1. Demographic characteristics of respondents.
Table 2. Migraine characteristics and prevalence among respondents.
Table 3. Migraine triggers/risk factors and symptoms.
Table 4. Management of migraine among respondents.
Table 5. Effectiveness of treatments used for managing migraines.
Table 6. Comparison of means between dependent and independent variables.
Table 7. Cross-tabulation of demographics and burden of migraine among respondents.
Table 8. Multiple linear regression predicting overall migraine burden among respondents.
Table 9. Multiple linear regression predicting job efficiency impact of migraine among respondents.
Table 10. Predictors for poor migraine management among respondents.
References
1. Amiri P, Kazeminasab S, Nejadghaderi SA, Migraine: A review on its history, global epidemiology, risk factors, and comorbidities: Front Neurol, 2022; 12; 800605
2. Aguilar-Shea AL, Membrilla JA, Diaz-de-Teran J, Migraine review for general practice: Aten Primaria, 2022; 54(2); 102208
3. Ashina M, Katsarava Z, Do TP, Migraine: Epidemiology and systems of care: The Lancet, 2021; 397(10283); 1485-95
4. Safiri S, Pourfathi H, Eagan A, Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019: Pain, 2022; 163(2); e293-e309
5. Steiner TJ, Stovner LJ, Vos T, Migraine is first cause of disability in under 50s: Will health politicians now take notice?: J Headache Pain, 2018; 19(1); 17
6. Ford JH, Jackson J, Milligan G, A real-world analysis of migraine: A cross-sectional study of disease burden and treatment patterns: Headache, 2017; 57(10); 1532-44
7. Viana M, Bottiroli S, Sances G, Factors associated to chronic migraine with medication overuse: A cross-sectional study: Cephalalgia, 2018; 38(14); 2045-57
8. Puledda F, Messina R, Goadsby PJ, An update on migraine: current understanding and future directions: J Neurol, 2017; 264(9); 2031-39
9. Razzak N, Khan H, Tariq H, Aslam M, Association between risk factors and migraine in Pakistani females: BMC Women’s Health, 2023; 23(1); 642
10. Athar F, Zahid A, Farooq M, Frequency of migraine according to the ICHD-3 criteria and its association with sociodemographic and triggering factors in Pakistan: A cross-sectional study: Annals of Medicine and Surgery, 2022; 82; 104589
11. Jamali YA, Khan HS, Channa R, Prevalence of migraine headache in Pakistan – A narrative review: Journal of Health and Rehabilitation Research, 2024; 4(1); 23-27
12. Johnson KT, Real-time assessment of the efficacy of an aerobic exercise and sleep education intervention for migraine, depression, and anxiety: A feasibility assessment: PhD Thesis, 2023, The University of Wisconsin-Milwaukee https://search.proquest.com/openview/f8ab56f0dac5a418dfc3bed2aa2d1194/1?pq-origsite=gscholar&cbl=18750&diss=y
13. Khan K, Arain MI, Asghar MA, Analysis of treatment cost and persistence among migraineurs: A two-year retrospective cohort study in Pakistan: PLoS One, 2021; 16(3); e0248761
14. Akgün N, Demirel EA, Açikgöz M, The effect of weather variables on the severity, duration, and frequency of headache attacks in the cases of episodic migraine and episodic tension-type headache: Turkish Journal of Medical Sciences, 2021; 51(3); 1406-12
15. Denney DE, Lee J, Joshi S, Whether Weather matters with migraine: Curr Pain Headache Rep, 2024; 28(4); 181-87
16. Van Casteren DS, Verhagen IE, Onderwater GL, Sex differences in prevalence of migraine trigger factors: A cross-sectional study: Cephalalgia, 2021; 41(6); 643-48
17. Le H, Tfelt-Hansen P, Skytthe A, Kyvik KO, Olesen J, Association between migraine, lifestyle and socioeconomic factors: A population-based cross-sectional study: J Headache Pain, 2011; 12(2); 157-72
18. Ray B, Paul N, Hazra A, Prevalence, burden, and risk factors of migraine: A community-based study from Eastern India: Neurol India, 2017; 65(6); 1280
19. Wöber C, Holzhammer J, Zeitlhofer J, Trigger factors of migraine and tension-type headache: Experience and knowledge of the patients: J Headache Pain, 2006; 7(4); 188-95
20. Knauf C, Heinrichs K, Süllwold R, Migraine self-management at work: A qualitative study: J Occup Med Toxicol, 2024; 19; 22
21. Chang YY, Tsai YT, Lai JN, The traditional Chinese medicine prescription patterns for migraine patients in Taiwan: A population-based study: J Ethnopharmacol, 2014; 151(3); 1209-17
22. Dent W, Stelzhammer B, Meindl M, Migraine attack frequency, duration, and pain intensity: Disease burden derived from a community-based survey in Northern Tanzania: November/December 2011: Headache: The Journal of Head and Face Pain, 2011; 51(10); 1483-92
23. Holden C, Design for migraine management: product proposal to mitigate social-emotional burdens of migraine: PhD Thesis, 2022, University of Oregon https://scholarsbank.uoregon.edu/xmlui/handle/1794/27331
24. Nanjundeswaraswamy TS, Divakar S, Determination of sample size and sampling methods in applied research: PES, 2021; 3(1); 25-32
25. Stewart WF, Lipton RB, Dowson AJ, Sawyer J, Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability: Neurology, 2001; 56(Suppl 1); WNL.56
26. Rahman MM, Sample size determination for survey research and non-probability sampling techniques: A review and set of recommendations: Journal of Entrepreneurship, Business and Economics, 2023; 11(1); 42-62
27. Bonfert MV, Sollmann N, Renner T, Burden of disease and lifestyle habits in adolescents and young adults prone to frequent episodic migraine: A secondary comparative analysis: J Child Health Care, 2022; 26(2); 215-27
28. Chen ZF, Kong XM, Yang CH, Global, regional, and national burden and trends of migraine among youths and young adults aged 15–39 years from 1990 to 2021: Findings from the global burden of disease study 2021: J Headache Pain, 2024; 25(1); 131
29. Ahmad F, Tariq R, Kaleem S: Sex/gender differences in migraine: Exploring pathophysiology, the impact of sex hormones, and tailored therapeutic approaches Published online 2024
30. Wei D, Loganathan T, Wong LP, Employees of the banking sector in Guizhou Province in China: Prevalence of migraine, symptoms, disability and occupational risk factors: J Headache Pain, 2023; 24(1); 52
31. Hjalte F, Olofsson S, Persson U, Linde M, Burden and costs of migraine in a Swedish defined patient population – A questionnaire-based study: J Headache Pain, 2019; 20(1); 65
32. Karlsson WK, Ashina H, Cullum CK, The Registry for Migraine (REFORM) study: Methodology, demographics, and baseline clinical characteristics: J4Headache Pain, 2023; 24(1); 70
33. Minen MT, Busis NA, Friedman S, The use of virtual complementary and integrative therapies by neurology outpatients: An exploratory analysis of two cross-sectional studies assessing the use of technology as treatment in an academic neurology department in New York City: Digital Health, 2022; 8; 205520762211095
34. Ganesh K, Lazar A, The work of workplace disclosure: Invisible chronic conditions and opportunities for design: Proc ACM Hum Comput Interact, 2021; 5, doi: 10.1145/3449147
35. Rosignoli C, Ornello R, Onofri A, Applying a biopsychosocial model to migraine: rationale and clinical implications: J Headache Pain, 2022; 23(1); 100
36. Tamminga SJ, Emal LM, Boschman JS, Individual-level interventions for reducing occupational stress in healthcare workers: Cochrane Database Syst Rev, 2023; 2023(5); CD002892
37. Kisan R, Sujan M, Adoor M, Effect of Yoga on migraine: A comprehensive study using clinical profile and cardiac autonomic functions: Int J Yoga, 2014; 7(2); 126-32
38. Wu Q, Liu P, Liao C, Tan L, Effectiveness of yoga therapy for migraine: A meta-analysis of randomized controlled studies: J Clin Neurosci, 2022; 99; 147-51
39. Coppola G, Brown JD, Mercadante AR, The epidemiology and unmet need of migraine in five european countries: Results from the national health and wellness survey: BMC Public Health, 2025; 25(1); 254
40. Sun L, Zhao R, You X, Association between family income to poverty ratio and severe headache/migraine in the American adults: Front Neurol, 2024; 15; 1427277
Figures
Tables
Table 1. Demographic characteristics of respondents.
Table 2. Migraine characteristics and prevalence among respondents.
Table 3. Migraine triggers/risk factors and symptoms.
Table 4. Management of migraine among respondents.
Table 5. Effectiveness of treatments used for managing migraines.
Table 6. Comparison of means between dependent and independent variables.
Table 7. Cross-tabulation of demographics and burden of migraine among respondents.
Table 8. Multiple linear regression predicting overall migraine burden among respondents.
Table 9. Multiple linear regression predicting job efficiency impact of migraine among respondents.
Table 10. Predictors for poor migraine management among respondents.
Table 1. Demographic characteristics of respondents.
Table 2. Migraine characteristics and prevalence among respondents.
Table 3. Migraine triggers/risk factors and symptoms.
Table 4. Management of migraine among respondents.
Table 5. Effectiveness of treatments used for managing migraines.
Table 6. Comparison of means between dependent and independent variables.
Table 7. Cross-tabulation of demographics and burden of migraine among respondents.
Table 8. Multiple linear regression predicting overall migraine burden among respondents.
Table 9. Multiple linear regression predicting job efficiency impact of migraine among respondents.
Table 10. Predictors for poor migraine management among respondents. In Press
Clinical Research
Body Weight and Insulin Resistance Indicators Among ChildrenMed Sci Monit In Press; DOI: 10.12659/MSM.951434
Clinical Research
Comparison of Radiographic Cervical Sagittal Alignment Parameters in Patients With Nonspecific Neck Pain, D...Med Sci Monit In Press; DOI: 10.12659/MSM.952950
Clinical Research
Combined Fibrinogen and Urinary α1-Microglobulin as Predictors of Respiratory Tract Infection in Children w...Med Sci Monit In Press; DOI: 10.12659/MSM.951066
Database Analysis
Evaluation of Salivary Total Oxidant Status (TOS) and Total Antioxidant Status (TAS) in Orthodontic Patient...Med Sci Monit In Press; DOI: 10.12659/MSM.952052
Most Viewed Current Articles
17 Jan 2024 : Review article 14,175,576
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,756,620
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,465,966
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 708,651
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387







